Paxman AB (publ) (PXMBF) Research

Paxman AB (publ), operating alongside its subsidiaries, specializes in engineering and marketing the Paxman scalp cooling system. This innovative solution aims to significantly mitigate hair loss experienced by patients undergoing chemotherapy, with its reach extending across a broad international presence including Europe, North America (the United States and Mexico), Asia (Japan and other areas), Oceania, and Central and South America. Its primary clientele consists of oncology clinics and healthcare institutions. The company also maintains a research and development partnership with the National University Hospital in Singapore, focused on creating a mobile cooling and compression apparatus. Founded in 1996, Paxman AB (publ) is headquartered in Karlshamn, Sweden.

Market snapshot

Symbol
PXMBF
Price
$3.50
Day change
0.00%
Market cap
$1.2B
P/E ratio
-110.13x
52-week range
3.5-3.5
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 2 months

Peer companies

  • BICO Group AB (publ) (BCCOY)
  • BICO Group AB (publ) (CLLKF)
  • Hofseth BioCare ASA (HOFBF)
  • Implanet S.A. (IMPZY)
  • Lumos Diagnostics Holdings Limited (LDXHF)
  • Orexo AB (publ) (ORXOY)
  • AVITA Medical, Inc. (RCEL)
  • Senzime AB (publ) (SNZZF)

Open Paxman AB (publ) (PXMBF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.